Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

Summary

This is a multicenter, randomized, placebo-control, phase III study to investigate hetrombopag in subjects with severe AA who are treated naive. 180 treated naive patients with SAA will be enrolled in the study. The primary objective of the study will be the rate of complete hematologic response at six months.

Timeline

Start

2019-03-05

Primary completion

2024-07-03

Completion

2024-07-03

Drugs

Indications